ADIPOQ and diabetes mellitus: These observations suggest that no single lipoprotein subclass, apolipoprotein or even adiponectin is a major driver of change in LFC in these insulin-treated patients with diabetes, although large VLDL, VLDL size, Apo B100, and Apo C3 may be related in some scenarios.